酸激酶M2通过增强SNAP23介导的血小板外细胞和由此产生的NETosis促进静脉血栓形成
Manasa K Nayak1, Gagan D Flora1, Ivan Budnik1
1Division of Hematology, Oncology, and Blood & Marrow Transplantation, Department of Internal Medicine, University of Iowa, Iowa City, IA.
Blood advances
|October 21, 2025
概括
在血小板中向酸盐激酶M2 (PKM2) 通过抑制中性粒细胞外细胞陷 (NET) 形成和血小板激活,减少深静脉血栓形成 (DVT). 这种代谢酶在DVT病理生物学中起着关键作用.
科学领域:
- 生物化学 生化学
- 血液学 血液学 血液学
- 血管生物学 血管生物学
背景情况:
- 代谢调节机制在深静脉血栓症 (DVT) 病理生物学中的作用基本上是未知的.
- 酸盐激酶M2 (PKM2) 是一种涉及血小板功能的代谢酶,但其对DVT的具体贡献仍未得到研究.
研究的目的:
- 调查血小板PKM2在深静脉血栓症 (DVT) 的发展中的作用.
- 探索针对PKM2作为DVT治疗策略的潜力.
主要方法:
- 使用了针对血小板的PKM2淘汰 (PKM2Plt-KO) 小鼠和野生型 (WT) 小鼠,用PKM2向小分子ML265.5治疗.
- 在下腔静脉 (IVC) 狭窄模型中评估血栓负担.
- 分析了中性细胞外细胞陷 (NETs),血小板脱粒标记物 (PF4),SNAP23酸化和IVC壁功能的肌谱.
- 在静脉剪切率下,在流量模型中评估人体全血.
主要成果:
- 与对照组相比,PKM2Plt-KO和ML265治疗小鼠的血栓负担降低.
- 观察到素化组合素H3 (NET标志物) 的水平降低和IVC血管功能改善.
- 抑制PKM2降低了血小板SNAP23酸化和PF4释放,降低了血小板释放的诱导NETosis的功效.
- ML265治疗显著降低了人体血液中的血小板-白细胞总量.
结论:
- 血小板中PKM2的遗传或药理向降低了DVT易感性.
- 抑制PKM2通过SNAP23限制了血小板α-颗粒细胞外,从而减少了血小板释放诱导的NETosis.
- 这些发现凸显了PKM2作为DVT的新治疗点.
相关概念视频
Venous Thrombosis I: Introduction
361
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
361
Formation of the Platelet Plug
8.7K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
8.7K
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
Clot Retraction and Fibrinolysis
8.4K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
8.4K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.1K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.1K
Structure and Function of Platelets
2.9K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
2.9K


